ROCK2 and myeloid neoplasm: Interestingly, hyper-activation of ROCK2 has also been observed in myeloid malignancies, where it promotes the growth and survival of leukemic cells through the constitutive activation of the PI3K/Rho/ROCK/myosin light chain pathway (59, 60).